Published by Josh White on 28th January 2019
(Sharecast News) - Networking and medical laboratory technologies provider BATM Advanced Communications has signed a conditional subscription and shareholders' agreement for an investment of up to $30m, it announced on Monday, to provide additional funds for the commercialisation of the molecular biology-based solutions being developed by Ador Diagnostics - its joint venture with Gamida for Life.